5825 SDS

===================================================================================================================

Section 1 -- PRODUCT AND COMPANY IDENTIFICATION

===================================================================================================================

HMIS CODES
Health 2
5825 Flammability 3
Reactivity 1

MANUFACTURER'S NAME: ADDRESS:
Cumberland Products Incorporated 50 Commerce Parkway
Hodgenville, KY 42748

EMERGENCY PHONE : (800) 424 - 9300 DATE PRINTED : 11/27/2013
INFORMATION PHONE : (800) 223 - 1918
FAX NUMBER : (800) 500 – 9812

===================================================================================================================

Section 2 -- COMPOSITION/INFORMATION ON HAZARDOUS INGREDIENTS

===================================================================================================================

% by WT CAS No. INGREDIENT UNITS VP
1 - 5% 79-20-9 Methyl Acetate 228
ACGIH TLV 200 ppm (TWA)
ACGIH STEL 250 ppm (TWA)
OSHA PEL 200 ppm (TWA)
OSHA STEL N/E
NIOSH 200 ppm (TWA)
NIOSH ST 250 ppm
NIOSH IDLH 3100 ppm
5 - 20% 67-64-1 Acetone 180
ACGIH TLV N/E
ACGIH STEL N/E
OSHA PEL N/E
OSHA STEL N/E
1 - 5% 110-43-0 Methyl n-Amyl Ketone 3
ACGIH TLV 50 ppm (TWA)
ACGIH STEL N/E
OSHA PEL 100 ppm (TWA)
OSHA STEL N/E
NIOSH 100 ppm (TWA)
NIOSH IDLH 800 ppm
0.1 - 1% 108-83-8 Diisobutyl Ketone (DIBK) 2
ACGIH TLV 25 ppm (TWA)
OSHA PEL 50 ppm (TWA)
NIOSH REL: 25 ppm (TWA)
NIOSH IDLH: 500 ppm
0.1 - 1% 8052-41-3 Mineral Spirits 2.000
ACGIH TLV 100 ppm (TWA)
OSHA PEL 500 ppm (TWA)
NIOSH REL: 350 mg/m3 (TWA)
NIOSH C 1800 mg/m3 (15-minute)
NIOSH IDLH: 20,000 mg/m3
0.1 - 1% 1330-20-7 Xylene 8
ACGIH TLV 100 ppm (TWA)
ACGIH STEL 150 ppm
OSHA PEL 100 ppm (TWA)
OSHA STEL N/E
NIOSH STEL: 150 ppm
NIOSH REL 100 ppm
5 - 20% 98-56-6 Parachlorobenzotriflouride 5.3
ACGIH TLV
ACGIH STEL 2.5 mg/m3
OSHA PEL 2.5 mg/m3
OSHA STEL
1 - 5% 95-63-6 1,2,4-Trimethylbenzene N/A
ACGIH TLV N/E
ACGIH STEL N/E
OSHA PEL N/E
OSHA STEL N/E

0.1 – 1% 1333-86-4 Carbon Black
ACGIH TLV 3.5 mg/m3 (TWA)
ACGIH STEL N/E
OSHA PEL 3.5 mg/m3 (TWA)
OSHA STEL N/E
NIOSH REL: 3.5 mg/m3 (TWA)
NIOSH Ca 0.1 mg PAHs/m3 (TWA)
NIOSH IDLH: 1750 mg/m3
0.1 - 1% 98-82-8 Isopropyl Benzene 8
ACGIH TLV 50 ppm
ACGIH STEL N/E
OSHA PEL 50 ppm
OSHA STEL N/E
1 - 5% 64742-95-6 Solvent Naphtha, petroleum, light aromatic .8
ACGIH TLV N/E
ACGIH STEL N/E
OSHA PEL N/E
OSHA STEL N/E
5 - 20% 65997-17-3 Silica, amorphous, precipitated and gel N/A
ACGIH TLV TWA: 10 mg/m3 inhalable
ACGIH STEL N/E
OSHA PEL N/E
OSHA STEL N/E
0.1 - 1% Mixture Diethylbenzene Isomer Mixture 1.3 mbar
ACGIH TLV
ACGIH STEL
OSHA PEL
OSHA STEL
0.1 - 1% 41556-26-7 Bis(1,2,2,6,6-Pentamethyl-4-piperidinyl) Sebacate
ACGIH TLV
ACGIH STEL
OSHA PEL
OSHA STEL
0.1 - 1% 104810-48-2 Poly Alcohol
ACGIH TLV N/E
ACGIH STEL N/E
OSHA PEL N/E
OSHA STEL N/E
0.1 - 1% 104810-47-1 Poly alcohol
ACGIH TLV N/E
ACGIH STEL N/E
OSHA PEL N/E
OSHA STEL N/E
0.1 - 1% 82919-37-7 Methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate .0001
ACGIH TLV N/E
ACGIH STEL N/E
OSHA PEL N/E
OSHA STEL N/E

===================================================================================================================

Section 3 -- HAZARDS IDENTIFICATION

===================================================================================================================

ROUTES OF EXPOSURE:
Exposure may be by INHALATION and/or SKIN or EYE contact, depending on conditions of use. To minimize exposure, follow recommendations for proper use, ventilation, and personal protective equipment.

EFFECTS OF OVEREXPOSURE:
Irritation of eyes, skin and upper respiratory system. May cause nervous system depression. Extreme overexposure may result in unconsciousness and possibly death.

SIGNS AND SYMPTOMS OF OVEREXPOSURE:
Headache, dizziness, nausea, and loss of coordination are indications of excessive exposure to vapors or spray mists. Redness and itching or burning sensation may indicate eye or excessive skin exposure.

MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE:
None generally recognized.

CANCER INFORMATION:
FOR COMPLETE DISCUSSION OF TOXICOLOGY DATA REFER TO SECTION 11.

===================================================================================================================
Section 4 -- FIRST AID MEASURES

===================================================================================================================
If INHALED:
If affected, remove from exposure. Restore breathing. Keep warm and quiet.

If on SKIN:
Wash affected area thoroughly with soap and water. Remove contaminated clothing and launder before re-use.

If in EYES:
Flush eyes with large amounts of water for 15 minutes. Get medical attention.

If SWALLOWED:
Do not induce vomiting. Get medical attention immediately.
===================================================================================================================
Section 5 -- FIRE FIGHTING MEASURES

===================================================================================================================
FLASH POINT LEL UEL
-4 F 0.8 16.0

EXTINGUISHING MEDIA:
Use National Fire Protection Association (NFPA) Class B extinguishers (carbon dioxide, dry chemical, or universal aqueous film forming foam) designed to extinguish NFPA Class IB flammable liquid fires. Water spray may be ineffective. Water spray may be used to cool closed containers to prevent pressure build-up and possible auto ignition or explosion when exposed to extreme heat.

UNUSUAL FIRE AND EXPLOSION HAZARDS:
Containers may explode when exposed to extreme heat. Application to hot surfaces requires special precautions. During emergency conditions overexposure to decomposition products may cause a health hazard. Symptoms may not be immediately apparent. Obtain medical attention.

SPECIAL FIRE FIGHTING PROCEDURES:
Full protective equipment including self-contained breathing apparatus should be used. Water spray may be ineffective. If water is used, fog nozzles are preferable. Water may be used to cool closed containers to prevent pressure build-up and possible auto ignition or explosion when exposed to extreme heat.
===================================================================================================================
Section 6 -- ACCIDENTAL RELEASE MEASURES

===================================================================================================================
STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED:
Provide maximum ventilation. Only personnel equipped with proper respiratory, skin, and eye protection should be permitted in the area. Remove all sources of ignition. Take up spilled material with sand,
vermiculite, or other noncombustible absorbent material and place in clean, empty containers for disposal. Only the spilled material and the absorbent should be placed in this container.
===================================================================================================================
Section 7 -- HANDLING RELEASE MEASURES

===================================================================================================================
PRECAUTIONS TO BE TAKEN IN HANDLING AND STORAGE:
Keep away from heat, sparks, and open flame. Vapors will accumulate readily and may ignite explosively. During use and until all vapors are gone: Keep area ventilated - Do not smoke - Extinguish all flames, pilot lights, and heaters - Turn off stoves, electric tools and appliances, and other sources of ignition. Consult NFPA Code. Use approved bonding and grounding procedures. Do not expose to temperature above 120F. Heat from sunlight, radiators, stoves, hot water, and other heat sources could cause container to burst. Do not take internally. Keep out of the reach of children.
===================================================================================================================
Section 8 -- EXPOSURE CONTROLS / PERSONAL PROTECTION

===================================================================================================================
PRECAUTIONS TO BE TAKEN IN USE:
Use only with adequate ventilation. Avoid contact with skin and eyes. Avoid breathing vapor and spray mist. Wash hands after using. This coating may contain materials classified as nuisance particulates (listed "as Dust" in section 2) which may be present at hazardous levels only during sanding or abrading of the dried film. If no specific dusts are listed in section 2, the applicable limits for nuisance dust are ACGIII TLV 10 mg/m3 (total dust), 3 mg/m3 (respirable fraction), OSHA PEL 15 mg/m3 (total dust), 5 mg/m3 (respirable fraction). Removal of old paint by sanding, scraping, or other means may generate dust or fumes that contain lead.

VENTILATION:
Local exhaust preferable. General exhaust acceptable if the exposure to materials in section 2 is maintained below applicable exposure limits. Refer to OSHA Standards 1910.94, 1910.107, 1910.108.
RESPIRATORY PROTECTION:
If personal exposure cannot be controlled below applicable limits by ventilation, wear a properly fitted organic vapor/particulate respirator approved by NIOSH/MSHA for protection against materials in section 2. When sanding or abrading the dried film, wear a dust/mist respirator approved by NIOSH/MSHA for dust which may be generated from this product, underlying paint, or the abrasive.
PROTECTIVE GLOVES:
None required for normal application of these products where minimal skin contact is expected. For long repeated contact, wear chemical resistant gloves.
EYE PROTECTION:
Wear safety spectacles with unperforated side shields.

OTHER PRECAUTIONS:
Intentional misuse by deliberately concentrating and inhaling the contents can be harmful of fatal.
===================================================================================================================
Section 9 -- PHYSICAL AND CHEMICAL PROPERTIES

===================================================================================================================
PRODUCT WEIGHT 10.176 lb/gal 1220 g/l
SPECIFIC GRAVITY 1.220
BOILING POINT 0 - 662 F -18 - 350 C
VOLATILES 55.9 % by wt 63.8 % by vol
EVAPORATION RATE Same as ether
VAPOR DENSITY Heavier than air
REGULATORY VOC 3.04 lb/gal 364 g/l
ACTUAL VOC 1.66 lb/gal 199 g/l
===================================================================================================================
Section 10 -- STABILITY AND REACTIVITY

===================================================================================================================
STABILITY:
This product is normally stable and will not undergo hazardous reactions.

CONDITIONS TO AVOID:
None Known.

INCOMPATIBILITY:
Avoid contact with strong alkalies, strong mineral acids, or strong oxidizing agents.

HAZARDOUS DECOMPOSITION PRODUCTS:
Carbon monoxide, carbon dioxide, oxides of sulfur, oxides of barium, lowers molecular weight polymer fractions.

HAZARDOUS POLYMERIZATION:
None Known.
===================================================================================================================
Section 11 -- TOXICOLOGICAL INFORMATION

===================================================================================================================
CAS No. Ingredient Name
--------------------------------------------------------------------------------------------------------------
79-20-9 Methyl Acetate
IARC Classification Not Established
Oral: LD50: >5000 mg/kg, rat
Dermal: LD50: >2000 mg/kg, rat
Inhalation: LC50: >49 mg/l, rat 4h
Skin Irritation: Non-irritant
Species Rabbit
Method OECD 404
Eye Irritation: Irritant
Species Rabbit eye
Method OECD 405
In vitro Mutagenicity: Ames test-negative with and without
metabolic activation

In vitro Mutagenicity: Mutagenicity (micronucleus test)-negative
Rat Inhalation
67-64-1 Acetone
IARC Classification Not Established
Acute oral toxicity: LD50 Rat: 5,800 mg/kg
Acute inhalation toxicity: LC Lo Rat: 16000 ppm, 4h
Acute dermal toxicity: LD50 Rabbit: 20,000 mg/kg

110-43-0 Methyl n-Amyl Ketone
IARC Classification Not Established
Acute oral toxicity LD50 Rat: 1670 mg/kg
Acute inhalation toxicity LC Lo Rat: 4000 ppm, (4h)
Acute dermal toxicity LD50 Rabbit: 13000 mg/kg

108-83-8 Diisobutyl Ketone (DIBK)
IARC Classification Not Established
Oral rat, LD50: 5750 mg/kg;
skin rabbit, LD50: 16 g/kg.
Human data: 25 ppm/15 minutes (standard Draize)
produced mild eye irritation.

8052-41-3 Mineral Spirits
LC50 RAT 4HR N/E
LD50 RAT N/E
IARC Classification Not Established
Eye - Standard Draize Test Rabbit, Dose: 500 mg/24H; Reaction: Moderate

1330-20-7 Xylene
IARC Classification Group 3
Acute oral toxicity: LD50 Rat: 4.300 mg/kg
Acute inhalation toxicity: No data available
Acute dermal toxicity: LD50 Rabbit: (>) 2,000 mg/kg

98-56-6 Parachlorobenzotrifluoride
IARC Classification Not Established
LD50: 11500 mg/kg Oral Rat
LC50: 20 gm/m³
95-63-6 1,2,4-Trimethylbenzene
IARC Classification Not Established
Acute oral toxicity LD50: 3,400 - 6,000 mg/kg (Rat)
Acute inhalation toxicity LC50: 18,000 mg/m3, 4 h (Rat)
Acute dermal toxicity LD50: > 3,160 mg/kg (rabbit)
Skin irritation rabbit, Moderately irritating
Eye irritation Rat, Slightly irritating
Sensitisation dermal: non-sensitizer (Guinea pig,
Maximization Test)
Repeated dose toxicity 20 Days, inhalation: NOAEL: < 100 ppm,
(rat, ) CNS depression.28 Days, oral: NOAEL: < 500 mg/kg, (rat,)Changes in:
kidney
Mutagenicity Genetic Toxicity in Vitro:
Ames: negative (Salmonella typhimurium,
Metabolic Activation: with/without)
Genetic Toxicity in Vivo: Sister
Chromatid Exchange: (mouse, )
Positive and negative results were seen
in various in vivo studies.
Cytogenetic assay: (Rat, )negative
Developmental Toxicity/Teratogenicity
rat, female, inhalation, daily, NOAEL
(teratogenicity): 0.19%, No Teratogenic
effects observed at doses tested., No
fetotoxicity observed at doses tested.

1333-86-4 Carbon Black
IARC Classification Group 2B
Acute toxicity:
Acute oral toxicity: LD50 (rat), > 8000 mg/kg
Primary irritation: skin (rabbit), non-irritative, index score
0.6/8 (4.0 = severe edema)
eye (rabbit), non-irritative, Draize score

10-17/110 (100 maximally irritating)
Sensitization: no animal data available.
Subchronic toxicity: Rat, inhalation, duration 90 days
Target organ: lungs
Effect: inflammation, hyperplasia, fibrosis
NOEL = 1.1 mg/m3
Chronic toxicity: Rat, oral, duration 2 years
Effect: no tumors
Mouse, oral, duration 2 years
Effect: no tumors
Mouse, dermal, duration 18 months
Effect: no skin tumors
Rat, inhalation, duration 2 years
Target organ: lungs.
Effect: inflammation, fibrosis, tumors
Note: Tumors in the rat lung are related to
the fine particle overload phenomenon
rather than to a specific chemical effect
of the dust particles in the lung. These
effects in rats have been reported in
studies on other inorganic insoluble
particles and appear to be species
specific. Tumors have not been observed in
other species (i.e., mouse and hamster) for
carbon black under similar circumstances
and study conditions.

Carcinogenicity In 1995 IARC concluded, “There is
inadequate evidence in humans for the
carcinogenicity of carbon black.” Based on
rat inhalation studies IARC concluded that
there is, “sufficient evidence in
experimental animals for the
carcinogenicity of carbon black,” IARC’s
overall evaluation was that, “Carbon black
is possibly carcinogenic to humans (Group
2B)”. This conclusion was based on IARC’s
guidelines which require such a
classification if one species exhibits
carcinogenicity in two or more studies.
In its 1987 review IARC concluded, “There
is sufficient evidence in experimental
animals for the carcinogenicity of carbon
black extracts.” Carbon black extracts are
classified as, possibly carcinogenic to
humans (Group 2B).
Carbon black is not designated a carcinogen
by the U.S. National Toxicology Program
(NTP), the U.S. Occupational Safety and
Health Administration (OSHA) or the
European Union (EU).
The American Conference of Governmental
Industrial Hygienists classifies carbon
black as A4, Not Classifiable as a Human
Carcinogen.
The U.S. National Institute of Occupational
Safety and Health (NIOSH) 1978 criteria
document on carbon black recommends that
only carbon blacks with PAH contaminant
levels greater than 0.1% require the
measurement of PAHs in air. As some PAHs
are Revised October 23, 2007 Page 5 of 6
Columbian Post-Treated English 2007-10-23
possible human carcinogens, NIOSH
recommends an exposure limit of 0.1 mg/m3
for PAHs in air, measured as the
cyclohexaneextractable fraction.
Sensitization: no animal data available.
Mutagenic effects In an experimental investigation,
mutational changes in the hprt gene were

reported in alveolar epithelial cells in
the rat following inhalation exposure to
carbon black. This observation is believed
to be rat specific and a consequence of
“lung overload” which led to chronic
inflammation and release of oxygen species.
(see Chronic toxicity above). This is thus
considered to be a secondary genotoxic
effect and thus carbon black itself would
not be considered to be mutagenic.
Reproductive effects: No effects have been reported in long-term
animal studies.
Epidemiology: Results of epidemiological studies of
carbon black production workers suggest
that cumulative exposure to carbon black
may result in small decrements in lung
function, as measured by FEV1. A recent
U.S. respiratory morbidity study suggested
a 27 ml decline in FEV1 from a 1 mg/m3
(inhalable fraction) exposure over a 40-
year period. An older European
investigation suggested an exposure to 1
mg/m3 (inhalable fraction) of carbon black
over a 40-year working-lifetime will result
in a 48 ml decline in FEV1. In contrast,
normal age related decline over a similar
period of time would be approximately 1200
ml. The relationship between symptoms and
exposure to carbon black is less clear. In
the U.S. study, 9% of the highest exposure
group (in contrast to 5% of the unexposed
group) reported symptoms consistent with
chronic bronchitis. In the European study,
methodological limitations in the
administration of the questionnaire limit
the drawing of definitive conclusions about
symptoms. This study, however, indicated a
link between carbon black and small
opacities on chest films, with negligible
effects on lung function. A study of carbon
black workers in the UK showed an elevated
incidence of lung cancer but it was not
considered to be related to carbon black
exposure. A study of workers at a large
German carbon black manufacturing facility
found increased lung cancer mortality among
German carbon black workers, but found no
apparent dose-response relationship between
lung cancer mortality and several
indicators of occupational exposure,
including years of employment and carbon
black exposure. The study concluded that
the high lung cancer mortality could not be
fully explained by selection, smoking, or
other occupational risk factors, but the
results also provided little evidence for
an effect from carbon black exposure. A
recent mortality study of US carbon black
workers found no association between
employment in carbon black production and
lung cancer or any other type of cancer.

Reproductive effects: No effects have been reported in
reproductive organs in long-term animal
studies.
98-82-8 Isopropyl Benzene
LC50 RAT 4HR 8000 ppm/4H
LD50 RAT 1400 mg/kg
IARC Classification Not Established

64742-95-6 Solvent Naphtha, petroleum, light aromatic
IARC Classification Not Established
Acute oral toxicity LD50: 3,500 mg/kg (rat, female)
LD50: > 5,000 mg/kg (rat, Male/Female)

Acute inhalation toxicity LC50: 10.2 mg/l, 4 h (rat)
LC50: 5.2 mg/l, 4 h (rat)
Acute dermal toxicity LD50: > 3,160 mg/kg (rabbit)

Skin irritation rabbit, Draize, Exposure Time: 24 h,
Slightly irritating

Eye irritation rabbit, Draize, Exposure Time: 24 h,
Slightly irritating

Sensitization dermal: non-sensitizer (guinea pig,
Maximization Test) dermal: non-sensitizer
(Human, Other method)
Repeated dose toxicity 90 D, Inhalation: NOAEL: 6.6 mg/l, (rat)
14 D, dermal: NOAEL: 3,750 mg/kg,(rabbit)
Mutagenicity
Genetic Toxicity in Vitro: Ames: negative (Salmonella typhimurium,
Metabolic Activation: with/without)
Carcinogenicity mouse, male, dermal, 2 Y, negative
rat, Male/Female, inhalation, 109 w, 6
hrs/day 7 days/week, positive, Kidney
carcinomas were found in male rats only
at all dose levels.
Toxicity to Reproduction/Fertility Two generation study, inhalation,
6 hrs/day 7 days/week, (rat, Male/Female)
NOAEL (F1): 500 ppm,
NOAEL (F2): 500 ppm
No effects on Reproductive parameters
observed at doses tested.
Three generation study,
inhalation, 6 hrs/day 7 days/week, (rat,
Male/Female) No effects on Reproductive
parameters observed at doses tested.
Developmental Toxicity/Teratogenicity rat, female, inhalation, NOAEL
(teratogenicity): > 1,573 ppm, No
Teratogenic effects observed at
doses tested.
65997-17-3 Silica, amorphous, precipitated and gel
LC50 RAT 4HR N/E
IARC Classification Not Established

Mixture Diethylbenzene Isomer Mixture
LD50 RAT 3 gm/kg
IARC Classification Not Established

41556-26-7 Bis(1,2,2,6,6-Pentamethyl-4-piperidinyl) Sebacate
IARC Classification Not Established

104810-48-2 Poly Alcohol
LC50 RAT 4HR N/E
LD50 RAT N/E
IARC Classification Not Established

104810-47-1 Poly alcohol
LC50 RAT 4HR N/E
LD50 RAT N/E
IARC Classification Not Established

82919-37-7 Methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate
IARC Classification Not Established
Acute toxicity
Oral: LD50/rat: > 2,000 mg/kg
Skin irritation: rabbit: non-irritant
Eye irritation : rabbit: non-irritant
Sensitization: guinea pig: sensitizing (OECD Guideline
406)

IARC Reference
IARC Group 1: The agent is carcinogenic to humans
This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an agent may be placed in this category when evidence of carcinogenicity in humans is less than sufficient but there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent acts through a relevant mechanism of carcinogenicity.

IARC Group 2A: The agent is probably carcinogenic to humans.
This category is used when there is limited evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals. In some cases, an agent may be classified in this category when there is inadequate evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals and strong evidence that the carcinogenesis is mediated by a mechanism that also operates in humans. Exceptionally, an agent may be classified in this category solely on the basis of limited evidence of carcinogenicity in humans. An agent may be assigned to this category if it clearly belongs, based on mechanistic considerations, to a class of agents for which one or more members have been classified in Group 1 or Group 2A.

IARC Group 2B: The agent is possibly carcinogenic to humans.
This category is used for agents for which there is limited evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals. It may also be used when there is inadequate evidence of carcinogenicity in humans but there is sufficient evidence of carcinogenicity in experimental animals. In some instances, an agent for which there is inadequate evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals together with supporting evidence from mechanistic and other relevant data may be placed in this group. An agent may be classified in this category solely on the basis of strong evidence from mechanistic and other relevant data.

IARC Group 3: The agent is not classifiable as to its carcinogenicity to humans.
This category is used most commonly for agents for which the evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. Exceptionally, agents for which the evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals may be placed in this category when there is strong evidence that the mechanism of carcinogenicity in experimental animals does not operate
in humans. Agents that do not fall into any other group are also placed in this category. An evaluation in Group 3 is not a determination of non-carcinogenicity or overall safety. It often means that further research is needed, especially when exposures are widespread or the cancer data are consistent with differing interpretations.

IARC Group 4: The agent is probably not carcinogenic to humans.
This category is used for agents for which there is evidence suggesting lack of carcinogenicity in humans and in experimental animals. In some instances, agents for which there is inadequate evidence of carcinogenicity in humans but evidence suggesting lack of carcinogenicity in experimental animals, consistently and strongly supported by a broad range of mechanistic and other relevant data, may be classified in this group.
===================================================================================================================
Section 12 -- ECOLOGICAL INFORMATION

===================================================================================================================
WASTE DISPOSAL METHOD:
Waste from this product may be hazardous as defined under the Resource Conservation and Recovery Act (RCRA) 40 CFR 261. Do not incinerate. Depressurize container. Dispose of in accordance with Federal, State, and Local regulations regarding pollution.
===================================================================================================================
Section 14 -- TRANSPORT INFORMATION

===================================================================================================================
Proper Shipping Name: Consumer Commodity
NOS Technical Name: ORM-D
Hazard Class: N/A
UN Number: N/A
Packing Group: N/A
===================================================================================================================
Section 15 -- REGULATORY INFORMATION

===================================================================================================================
Canadian Regulations:
CEPA (Canadian Environmental Protection Act):
All substances in this product are listed on the Canadian Domestic Substance List (DSL) or are not required to be listed.

US Regulations:
This product contains the following substances subject to the reporting requirements of Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 and 40 CFR Part 372.

SARA 313:
CAS No. CHEMICAL/COMPOUND % by WT
--------------------------------------------------------------------------------------------------------------
8052-41-3 Mineral Spirits 0.8
1330-20-7 Xylene 0.2
98-82-8 Isopropyl Benzene 0.2

TSCA CERTIFICATION:
U.S. TSCA: This product and/or all of its components are listed on the U.S. TSCA Inventory or is otherwise exempt form TSCA Inventory reporting requirements.
===================================================================================================================
Section 16 -- OTHER INFORMATION

===================================================================================================================
DISCLAIMER:
Do not handle until the manufacturer's safety precautions have been read and understood. Regulations require that all employees be trained on Material Safety Data Sheets for all products with which they come in contact. While we believe that the data contained herein is accurate and derived from qualified sources, the data are not to be taken as a warranty or representation for which we assume legal responsibility. They are offered solely for your consideration, investigation, and verification. Any use of these data and information must be determined by the user to be in accordance with applicable federal, state, provincial, and local laws and regulations.
==============================================================================================================
ENVIRONMENTAL DATA SHEET
All data given below are MAXIMUM THEORETICAL VALUES based on the product AS CURRENTLY FORMULATED. Variations
may occur on individual batches due to adjustments made during production.

PRODUCT NUMBER
CP - 5825
PRODUCT NAME
2.8 VOC Vintage Hot Rod Red Oxide (Satin)

PRODUCT WEIGHT SPECIFIC GRAVITY FLASH POINT
10.176 lb/gal 1.220 -4 F

VOLATILE INGREDIENTS CERC. SARA HAPS PCT PCT
NAME CAS No. 313 112 by by
TC Wt Vol
--------------------------------------------------------------------------------------------------------------
Methyl Acetate 79-20-9 X 3.6 4.7
Methyl n-Amyl Ketone 110-43-0 X 3.9 5.8
Mineral Spirits 8052-41-3 X 0.8 1.2
Xylene 1330-20-7 X X X 0.2 0.3
Isopropyl Benzene 98-82-8 X X 0.2 0.2
==============================================================================================================
VOLATILE ORGANIC COMPOUNDS
A. Coating Density 10.18 lb/gal 1221 g/l
B. Total Volatiles 55.9 % by wt 63.8 % by vol
Exempt Volatiles 39.6 % by wt 45.4 % by vol
Water 0.0 % by wt 0.0 % by vol
C. Organic Volatiles 16.3 % by wt 18.4 % by vol
D. Percent Non-Volatile 44.1 % by wt 36.2 % by vol
E. Regulatory VOC 3.04 lb/gal 364 g/l
Actual VOC 1.66 lb/gal 199 g/l
Solids 4.49 lb/gal 538 g/l
WASTE DISPOSAL
Waste from this product may be hazardous as defined under the Resource Conservation and Recovery Act (RCRA) 40 CFR 261. Waste must be tested for ignitability to determine the applicable EPA hazardous waste numbers. The addition of reducers or other additives to this product may substantially alter the above data. Since conditions of use are outside our control, we make no warranties, express or implied, and assume no liability in connection with any use of this information.